Morgan Stanley lowered its price target on United Therapeutics on July 19, 2025.
1 report, 1 independent
Updated Jul 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley lowered its price target on United Therapeutics on July 19, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley increased its price target for SLM Corporation on September 2, 2026.
- Morgan Stanley increased its price target for TaskUs on September 22, 2026.
- Morgan Stanley raised its price target for Cardinal Health on August 8, 2025.
- Morgan Stanley increased its price target for MPLX LP on September 25, 2026.
- Morgan Stanley raised its price target for AT&T on July 19, 2025.
Coverage
Newest first; wire copies grouped- Insider MonkeyMorgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating United Therapeutics Corporation (NASDAQ:UTHR) is one of the high-margin pharma stocks to buy now. Morgan Stanley has